Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Everolimus Immunoassay

FDA product code OUF · 2 cleared devices

Class 2 Clinical Toxicology
Regulation
21 CFR 862.3840
Review panel
TX
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
2011-02-11 – 2013-08-20

To quantify everolimus in whole blood.

↑